Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,554 shares at $283.84 ($440K) on 2020-06-02, disclosed to the SEC on 2020-06-03.
Seasonal sale ($440k) by Director — this insider has traded VRTX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $279.52 | 50 | $14K | 3.2% |
| 2 | $281.20 | 200 | $56K | 12.8% |
| 3 | $282.86 | 313 | $89K | 20.1% |
| 4 | $282.86 | 313 | $89K | 20.1% |
| 5 | $283.84 | 289 | $82K | 18.6% |
| 6 | $283.84 | 289 |
| $82K |
| 18.6% |
| 7 | $284.62 | 50 | $14K | 3.2% |
| 8 | $285.73 | 50 | $14K | 3.2% |
| Total | $283.05 avg | 1,554 | $440K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |